Synthesis of pyrrolo[2,3-d]pyrimidine derivatives and their antiproliferative activity against melanoma cell line

Authors
Jung, Myung-HoKim, HwanChoi, Won-KyoungEl-Gamal, Mohammed I.Park, Jin-HunYoo, Kyung HoSim, Tae BoLee, So HaBaek, DaejinHah, Jung-MiCho, Jung-HyuckOh, Chang-Hyun
Issue Date
2009-12-01
Publisher
Pergamon Press Ltd.
Citation
Bioorganic & Medicinal Chemistry Letters, v.19, no.23, pp.6538 - 6543
Abstract
Synthesis of a new series of diarylureas and amides having pyrrolo[2,3-d]pyrimidine scaffold is described. Their in vitro antiproliferative activities against A375 human melanoma cell line and HS 27 fibroblast cell line were tested and the effect of substituents on pyrrolo[2,3-d]pyrimidine was investigated. The newly synthesized compounds, except N-acetyl derivatives (Id, Ie, and Im), generally showed superior or similar activity against A375 to Sorafenib. Among all of these derivatives, compounds Iq and Ir having imidazole and morpholine moieties, respectively, showed the most potent antiproliferative activity against A375. (C) 2009 Published by Elsevier Ltd.
Keywords
REFRACTORY SOLID TUMORS; FACTOR RECEPTOR INHIBITOR; RAF KINASE; SUBSTITUTED UREAS; PHASE-I; BAY-43-9006; THERAPY; PHARMACOKINETICS; INTERLEUKIN-2; PATHWAY; REFRACTORY SOLID TUMORS; FACTOR RECEPTOR INHIBITOR; RAF KINASE; SUBSTITUTED UREAS; PHASE-I; BAY-43-9006; THERAPY; PHARMACOKINETICS; INTERLEUKIN-2; PATHWAY; Pyrrolo[2,3-d]pyrimidine; A375; HS 27; Antiproliferative activity; Melanoma
ISSN
0960-894X
URI
https://pubs.kist.re.kr/handle/201004/131889
DOI
10.1016/j.bmcl.2009.10.051
Appears in Collections:
KIST Article > 2009
Files in This Item:
There are no files associated with this item.
Export
RIS (EndNote)
XLS (Excel)
XML

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE